Literature DB >> 27240018

The effect of pulmonary rehabilitation on COPD exacerbation frequency per year.

Hulya Sahin1, Yelda Varol2, Ilknur Naz3, Nimet Aksel2, Fevziye Tuksavul1, Ayse Ozsoz2.   

Abstract

OBJECTIVE: We aimed to investigate the effect of pulmonary rehabilitation (PR) on the number of exacerbations in chronic obstructive pulmonary diseases (COPD) patients.
METHODS: The study included 82 patients referred to our hospital's PR Unit between June 2013 and June 2014. Patients were divided into two groups, including those with low exacerbation risk (low number of exacerbations) (Groups A + B) and those experiencing frequent exacerbations (Groups C+ D) according to the combined COPD assessment.
RESULTS: Patients were included in a PR program that consisted of 16 sessions in total, held twice a week over a period of 2 months. After one year, patients were called to find out about their COPD exacerbation frequency. Groups presented similar characteristics in terms of age, BMI and smoking duration prior to the PR program (P > .05). The frequent exacerbators had lower scores in exercise capacity, arterial oxygenation, health-related quality of life and anxiety (P < .05). However, both groups exhibited significantly improved scores in the perceived dyspnea, FEV1 percentage, arterial oxygenation, exercise capacity, quality of life and anxiety after pulmonary rehabilitation (P < .05). The number of post-PR emergency referrals and hospitalization (P < .0001, P = .04), and depression score decreased significantly among the frequent exacerbators. Group 1 presented insignificant changes in the number of emergency referrals and hospitalizations (P < .05).
CONCLUSION: Notwithstanding disease severity, PR treatment is reported to have positive effects on COPD patients in terms of perceived dyspnea, exercise capacity, arterial oxygenation, quality of life, anxiety and depression. This study found reduced number of emergency referrals and hospitalization among COPD patients with frequent exacerbations after PR.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  COPD; combined assessment; exacerbation; pulmonary rehabilitation

Mesh:

Year:  2016        PMID: 27240018     DOI: 10.1111/crj.12507

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

Review 1.  The key questions in rehabilitation in thoracic surgery.

Authors:  Kajan Mahendran; Babu Naidu
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Pulmonary Rehabilitation Reduces Emergency Admission and Hospitalization Rates of Patients with Chronic Respiratory Diseases.

Authors:  İpek Özmen; Elif Yıldırım; Murat Öztürk; Birsen Ocaklı; Reyhan Yıldız; Rüya Aydın; Meral Karakış; Özgür Yılmaz; Emine Aksoy
Journal:  Turk Thorac J       Date:  2018-09-13

Review 3.  Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension.

Authors:  Pasquale Ambrosino; Tiziana Bachetti; Silvestro Ennio D'Anna; Brurya Galloway; Andrea Bianco; Vito D'Agnano; Antimo Papa; Andrea Motta; Fabio Perrotta; Mauro Maniscalco
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-27

4.  Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.

Authors:  Peter A Jacobsen; Alex J van 't Hul; Remco S Djamin; Jeanine C Antons; Marianne de Man; Ulla Møller Weinreich; Martijn A Spruit; Daisy J A Janssen
Journal:  Respir Res       Date:  2021-05-12

5.  Airway clearance techniques for patients with acute exacerbations of chronic obstructive pulmonary disease: Physical therapy practice in Sweden.

Authors:  Elisabeth Westerdahl; Christian Osadnik; Margareta Emtner
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

6.  Effects of a Comprehensive Care Program on the Readmission Rate and Adherence to Treatment in Elderly Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Ali Khosravi; Ali Ravari; Tayebeh Mirzaei; Mohammadreza Gholamrezapour
Journal:  Tanaffos       Date:  2020-12

Review 7.  Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease.

Authors:  Takudzwa Mkorombindo; Mark T Dransfield
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.